Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights - MRVI

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Maravai LifeSciences Holdings, Inc. regarding a class action lawsuit due to allegations of misleading statements and inadequate internal controls over financial reporting [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from August 7, 2024, to February 24, 2025 [1]. - Allegations include that Maravai lacked adequate internal controls over financial reporting related to revenue recognition, leading to inaccurate revenue recognition during fiscal 2024 [1]. - The complaint also states that the company's goodwill was overstated, and positive statements made by defendants about the company's business were materially misleading [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by May 5, 2025, to potentially become lead plaintiffs [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].